Latest Biotech News

Cellares signed a long‑term lease at Leiden Bio Science Park to establish a European Smart Factory using its automated Cell Shuttle manufacturing platforms and Cell Q quality systems. The...

Vedanta Biosciences said it significantly reduced headcount to concentrate capital and manpower on its lead live‑biotherapeutic VE303, a bacterial consortium targeting recurrent Clostridioides...

AbbVie and Genmab announced that Epkinly failed to prolong overall survival in a Phase 3 trial for diffuse large B‑cell lymphoma (DLBCL). The multicenter study enrolled patients who had received...

ImmunityBio reported encouraging early results from its off‑the‑shelf CD19 CAR‑NK program in a small Phase 1 cohort for Waldenström’s lymphoma, with complete responses sustained up to 15 months in...

Johnson & Johnson reported Phase 3 data showing Tecvayli improved outcomes versus widely used regimens in earlier settings of multiple myeloma. In the MajesTEC‑9 study, J&J said patients...

The Advanced Research Projects Agency for Health (ARPA‑H) awarded UC San Diego up to $25,771,771 to develop patient‑specific, 3D bioprinted human livers under the agency’s PRINT program. The...

iRegene Therapeutics said the FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation to its allogeneic iPSC‑derived product NouvNeu001 for Parkinson’s disease, adding to an existing...

Boston Scientific announced an agreement to acquire Penumbra for approximately $14.5 billion to expand into thrombectomy and embolization markets, the companies said. The deal would add Penumbra’s...

Vedanta Biosciences said it significantly reduced headcount and refocused operations to concentrate resources on its lead live bacterial consortium, VE303, which is in Phase 3 development for...

The Blood Profiling Atlas in Cancer (BloodPAC) consortium published generic analytical validation protocols for tumor‑informed circulating tumor DNA (ctDNA) assays designed to monitor minimal...

Labcorp expanded its molecular residual disease (MRD) portfolio with nationwide launches of Plasma Detect ID and Plasma Detect Genome assays, designed to detect circulating tumor DNA down to...

Veracyte outlined plans to launch TrueMRD, a sequencing‑based minimal residual disease assay, in the first half of the year with an initial indication for muscle‑invasive bladder cancer (MIBC)....

ARPA‑H has awarded the University of California San Diego roughly $25.8 million to develop patient‑specific, 3D‑bioprinted human livers under the agency’s PRINT program. The multidisciplinary...

Two market‑moving developments accelerated the oral GLP‑1 race this week: Novo Nordisk reported more than 3,000 prescriptions for its newly launched Wegovy oral pill in the first week, signaling...

Boston Scientific announced a $14.5 billion agreement to acquire Penumbra, a maker of thrombectomy and embolization devices, aiming to expand into fast‑growing vascular and clot‑removal markets....

Johnson & Johnson reported Phase‑3 trial results showing Tecvayli improved progression‑free survival and produced a survival signal in patients with earlier‑line multiple myeloma, data the company...

Researchers adapted a previously developed gene‑drive strategy for an African mosquito strain and established a secure facility in Tanzania to test transmission‑blocking modifications against...

A research team evaluated the CRISPR–Cas3 system for therapeutic genome editing to permanently reduce transthyretin (TTR) production, demonstrating a distinct mechanism compared with Cas9. The...

Researchers introduced PanMAN (Pangenome Mutation‑Annotated Network), a new data structure and compression method that encodes phylogenies, mutations and whole‑genome alignments to dramatically...

A Rice University team unveiled CLASSIC, a platform that combines long‑ and short‑read sequencing with AI/ML design to generate and map hundreds of thousands to millions of genetic circuit...